Cleared Special

K140412 - ANS1 SOFTWARE

K140412 is an FDA 510(k) clearance for ANS1 SOFTWARE, manufactured by Ld Technology, LLC. The device is a Class 2 Cardiovascular device with product code DXN cleared through the Special 510(k) pathway after a 93-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2014
Decision
93d
Days
Class 2
Risk

K140412 is an FDA 510(k) clearance for the ANS1 SOFTWARE. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Ld Technology, LLC (Miami, US). The FDA issued a Cleared decision on May 22, 2014 after a review of 93 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Ld Technology, LLC devices

FDA 510(k) Submission Details - K140412

510(k) Number K140412 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 18, 2014
Decision Date May 22, 2014
Days to Decision 93 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
32d faster than avg
Panel avg: 125d · This submission: 93d
Pathway characteristics
Modification to existing cleared device.

DXN Device Classification - Class 2, Special Controls

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 843
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K140412.
QARDIOARM
K140067 · Qardio, Inc. · Jun 2014
DIGITAL AUTOMATIC BLOOD PRESSURE MONITOR BPM20 SERIES
K140583 · Grandway Technology (Shenzhen) Limited · Jun 2014
EV1000 CLINICAL PLATFORM WITH CLEARSIGHT TM FINGER CUFF OR CLEARSIGHT TM SYSTEM
K140312 · Edwards Lifesciences, LLC · Jun 2014
FORA CARE BLOOD PRESSURE MONITORING SYSTEM
K133588 · Foracare, Inc. · Apr 2014
WITHINGS BLOOD PRESURE MONITOR
K133125 · Withings · Mar 2014
BPROSOFT CASP PC SOFTWARE
K131916 · Healthstats International Pte. , Ltd. · Mar 2014